Transcription of Guidelines for cryoprecipitate transfusion
{{id}} {{{paragraph}}}
VOL. 49 NO. 8, OCTOBER2007BC MEDICAL JOURNAL441 ABSTRACT: The literature showsthere is often inappropriate use of blood products, including cryo -precipitate plasma, because of in -adequate education of for cryoprecipitate trans - fusion have been developed by theTransfusion Medicine Advisory Groupof British Columbia to educate clini-cians and address transfusion prac-tices in the province. These guide -lines are based on a MEDLINE search and consultation with hema -to pathologists and clinicians. At pre-sent, transfusion of cryoprecipitateis indicated for hypofibrinogen emia/dysfibrinogenemia, von Willebranddisease, hemophilia A, factor XIII deficiency, and management ofbleeding related to thrombolytictherapy. cryoprecipitate should notbe used to prepare fibrin glue or totreat sepsis. The transfusion Medicine Ad -visory Group (TMAG) of BChas prepared Guidelines to pro-vide physicians with current informa-tion on the appropriate use of cryopre-cipitate plasma.
of blood products, including cryo - precipitate plasma, because of in - adequate education of physicians. Guidelines for cryoprecipitate trans-fusion have been developed by the Transfusion Medicine Advisory Group of British Columbia to educate clini-cians and address transfusion prac-tices in the province. These guide-lines are based on a MEDLINE
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}